WENO Makes e-Prescribing History by Offering Free Electronic Prescribing for Controlled Substances
07 janv. 2021 08h02 HE
|
WENO Exchange
WENO’s free EPCS offering expected to accelerate DEA callsto investigate noncompliant pharmacies AUSTIN, Texas, Jan. 07, 2021 (GLOBE NEWSWIRE) -- For prescribers that need to Electronically...
URAC and 80 Organizations Call on DEA to Create Registry for Telemedicine Treatment of Substance Abuse
27 oct. 2020 15h58 HE
|
URAC
Washington, DC, Oct. 27, 2020 (GLOBE NEWSWIRE) -- On Oct. 26th, URAC joined 80 other organizations, led by the Alliance for Connected Care, in calling for the U.S. Drug Enforcement Administration...
Endonovo Therapeutics’ Offers FDA Cleared Solution to Opioid Epidemic Which Has Significantly Increased During the COVID Pandemic.
08 oct. 2020 08h00 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today a new marketing and public awareness campaign around their FDA...
View Systems, Inc.’s (VSYM) Sannabis Announces Approval by the United States Department of Agriculture (USDA) to Import Cannabis into the United States from South America.
31 janv. 2020 09h05 HE
|
VIEW SYSTEMS INC
Import Permit for Cannabis issued to Company President yesterday. Miami, Florida, Jan. 31, 2020 (GLOBE NEWSWIRE) -- View Systems, Inc.’s (VSYM), medical marijuana and hemp subsidiary, Sannabis...
Akers Biosciences Continues Strategic Review; Explores Leveraging its 30-years of Laboratory Operations to Enter into the Hemp and Minor Cannabinoid Processing Industry
05 déc. 2019 08h45 HE
|
Akers Biosciences Inc.
· Establishes Advisory Board appointing Bob Hoban and Michael Patterson Thorofare, New Jersey, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company” or “we”) (NASDAQ:...
CURE Pharmaceutical Secures Patent on Oral Thin Film Containing Bioactive Cannabinoid Molecules
22 mai 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the issuance of U.S. Patent No. 10,307,397,...
CURE Pharmaceutical Expands U.S. DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant
12 mars 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has broadened its U.S. Drug Enforcement...
Imprivata Collaborates with DigiCert to Enable Remote Identity Proofing for EPCS
05 déc. 2018 09h00 HE
|
Imprivata
LEXINGTON, Mass., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Imprivata®, the healthcare IT security company, today announced a new collaboration with DigiCert, the world’s leading provider of TLS/SSL, IoT...
CURE Pharmaceutical Secures U.S. DEA Approval to Manufacture Cannabinoid-based Pharmaceuticals
26 nov. 2018 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has secured a new registration with the...
Vitality Biopharma Receives DEA Renewal for Cannabinoid Pharma Development Program
20 juin 2018 08h00 HE
|
Vitality Biopharma, Inc
LOS ANGELES, June 20, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid...